152 results
Goal: Towards implementation of ART in women with cervical cancer to increase RT precision and reduce the risk of late radiation complications.Study question: What is the effect of bladder filling on the position of the uterus and tumour in women…
The primary objective of this study is to evaluate the additional value of biomarker HE4, as second step after the RMI score, in the triage of patients with an ovarian mass. We aim to improve the referral process to oncological centers. Secondary…
The primary objective of the phase II is to determine the progression free survival (PFS) at 1 year according to the RECIST 1.1 of the combination of pazopanib with weekly paclitaxel and carboplatin in platinum-resistant ovarian, fallopian tube or…
To assess the potential of [18F]FB-IL2 PET to detect the infiltration of IL2 receptor (IL2R) positive immune cells in cervical cancer tissue during radiochemotherapy treatment using IL2 receptor positive cells in tumor biopsies as (golden standard).
Primary: • Evaluate the safety of TIL, alone or with IFNα, in patients with recurrent platinum sensitive EOC during standard chemotherapy (carboplatin and paclitaxel).Secondary: • Evaluate signs of activity and underlying mechanisms (response rate,…
The primary objective of this study is to validate prospectively that testing for the DNA methylation status of some tumor suppressor genes predicts (non-)regression of a CIN2/3 lesion, and therefore can lead to prevention of overtreatment.
primary objective of this project is to explore the relief of symptoms due to ROC, the speed with which this occurs by different chemotherapy schedules and development of complaints due to the regimen of chemotherapy. Secondary we intend (1) to…
The objective is to evaluate safety, toxicity and expansion of intraperitoneally infused UCB-derivedex vivo-generated NK cells in patients diagnosed with recurrent ovarian cancer. Infusion with and without lymphodepleting chemotherapy will be…
Primary objectives: • To assess the safety and tolerability of different doses of the ISA101 vaccine with or without pegylated IFNα as combination therapy with carboplatin and paclitaxel.• To qualitatively assess the safety profile of ISA101b…
Objectives: 1. The primary objective is to evaluate the safety and immune modulation of TIL plus IFN* in epithelial ovarian cancer (EOC) patients and to determine the optimal dose of IFN* that can be given in combination with chemotherapy.2.…
To induce a vaccine specific immune response, hereby we hope to introduce the possibility of a new treatment to improve patient outcome and survival.
Objective The objective of this study is to assess which risk scoring model is most cost-effective for the discrimination between benign and malignant ovarian tumors that guides referral decisions for women with ovarian tumors in the Netherlands…